# A Study to Detect Radioactivity of [14C]-OPC-167832 in Urine and Feces in Healthy Men

> **NCT07314320** · PHASE1 · COMPLETED · sponsor: **Otsuka Pharmaceutical Development & Commercialization, Inc.** · enrollment: 8 (actual)

## Conditions studied

- Healthy Volunteers

## Interventions

- **DRUG:** [14C]-OPC-167832

## Key facts

- **NCT ID:** NCT07314320
- **Lead sponsor:** Otsuka Pharmaceutical Development & Commercialization, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2023-11-20
- **Primary completion:** 2023-12-27
- **Final completion:** 2023-12-27
- **Target enrollment:** 8 (ACTUAL)
- **Last updated:** 2026-01-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07314320

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07314320, "A Study to Detect Radioactivity of [14C]-OPC-167832 in Urine and Feces in Healthy Men". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT07314320. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*